TheraVet SA 31A.F Stock
TheraVet SA Price Chart
TheraVet SA 31A.F Financial and Trading Overview
| TheraVet SA stock price | 0.61 EUR |
| Previous Close | 1.89 EUR |
| Open | 1.81 EUR |
| Bid | 1.75 EUR x N/A |
| Ask | 1.82 EUR x N/A |
| Day's Range | 1.81 - 1.81 EUR |
| 52 Week Range | 1.75 - 4.51 EUR |
| Volume | 50 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 5.93M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.5 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
31A.F Valuation Measures
| Enterprise Value | 3.96M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.7030299 |
| Price/Book (mrq) | 0.77368194 |
| Enterprise Value/Revenue | 2.47 |
| Enterprise Value/EBITDA | -1.44 |
Trading Information
TheraVet SA Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -58.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4.51 EUR |
| 52 Week Low | 1.75 EUR |
| 50-Day Moving Average | 2.39 EUR |
| 200-Day Moving Average | 2.91 EUR |
31A.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 3.22M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -144.56% |
| Operating Margin (ttm) | -173.35% |
| Gross Margin | -61.98% |
| EBITDA Margin | -171.54% |
Management Effectiveness
| Return on Assets (ttm) | -16.56% |
| Return on Equity (ttm) | -26.97% |
Income Statement
| Revenue (ttm) | 1.6M EUR |
| Revenue Per Share (ttm) | 0.5 EUR |
| Quarterly Revenue Growth (yoy) | -32.89% |
| Gross Profit (ttm) | N/A |
| EBITDA | -2747790 EUR |
| Net Income Avi to Common (ttm) | -2315628 EUR |
| Diluted EPS (ttm) | -0.71 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.19M EUR |
| Total Cash Per Share (mrq) | 0.99 EUR |
| Total Debt (mrq) | 1.05M EUR |
| Total Debt/Equity (mrq) | 13.94 EUR |
| Current Ratio (mrq) | 3.286 |
| Book Value Per Share (mrq) | 2.333 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1031193 EUR |
| Levered Free Cash Flow (ttm) | -2109851 EUR |
Profile of TheraVet SA
| Country | Germany |
| State | N/A |
| City | Charleroi |
| Address | Avenue Jean Mermoz 32/1 |
| ZIP | 6041 |
| Phone | N/A |
| Website | https://www.thera.vet/en |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 11 |
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET, an injectable self-hardening phosphocalcic bone void filler for osteointegration, osteoinduction, and bone remodeling properties; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid, species specific plasma, and an active pharmaceutical component. The company also provides various products, such as BIOCERA-VET bone surgery RTU, a ready-to-use highly injectable self-hardening calcium-phosphate cement; BIOCERA-VET smartgraft, a naturally osteoconductive bone graft; BIOCERA-VET granules, an affordable biocompatible calcium-phosphate bone substitute; and BIOCERA-VET osteosarcoma RTU, a ready-to-use highly injectable calcium-phosphate bone substitute for cementoplasty. TheraVet SA was incorporated in 2017 and is based in Gosselies, Belgium.
Q&A For TheraVet SA Stock
What is a current 31A.F stock price?
TheraVet SA 31A.F stock price today per share is 0.61 EUR.
How to purchase TheraVet SA stock?
You can buy 31A.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TheraVet SA?
The stock symbol or ticker of TheraVet SA is 31A.F.
Which industry does the TheraVet SA company belong to?
The TheraVet SA industry is Biotechnology.
How many shares does TheraVet SA have in circulation?
The max supply of TheraVet SA shares is 3.52M.
What is TheraVet SA Price to Earnings Ratio (PE Ratio)?
TheraVet SA PE Ratio is now.
What was TheraVet SA earnings per share over the trailing 12 months (TTM)?
TheraVet SA EPS is -0.5 EUR over the trailing 12 months.
Which sector does the TheraVet SA company belong to?
The TheraVet SA sector is Healthcare.